《WORLD J PEDIATR,2月7日,Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-02-08
  • Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement

    Kunling Shen, Yonghong Yang, […]Global Pediatric Pulmonology Alliance

    World Journal of Pediatrics

    DOIhttps://xs.scihub.ltd/https://doi.org/10.1007/s12519-020-00343-7

    Abstract

    Since the outbreak of 2019 novel coronavirus infection (2019-nCoV) in Wuhan City, China, by January 30, 2020, a total of 9692 confirmed cases and 15,238 suspected cases have been reported around 31 provinces or cities in China. Among the confirmed cases, 1527 were severe cases, 171 had recovered and been discharged at home, and 213 died. And among these cases, a total of 28 children aged from 1 month to 17 years have been reported in China. For standardizing prevention and management of 2019-nCoV infections in children, we called up an experts’ committee to formulate this experts’ consensus statement. This statement is based on the Novel Coronavirus Infection Pneumonia Diagnosis and Treatment Standards (the fourth edition) (National Health Committee) and other previous diagnosis and treatment strategies for pediatric virus infections. The present consensus statement summarizes current strategies on diagnosis, treatment, and prevention of 2019-nCoV infection in children.

  • 原文来源:https://link.springer.xilesou.top/article/10.1007/s12519-020-00343-7
相关报告
  • 《JMV,2月7日,Evolving status of the 2019 novel coronavirus Infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring [Commentary/Review]》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-08
    • Evolving status of the 2019 novel coronavirus Infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring [Commentary/Review] Shu‐Yuan Xiao Yingjie Wu Huan Liu First published:07 February 2020 https://doi.org/10.1002/jmv.25702 Abstract The novel coronavirus (nCoV‐2019) outbreak in Wuhan, China has spread rapidly nationwide, with some cases occurring in other parts of the world. Although most patients present with mild febrile illness with patchy pulmonary inflammation, a significant portion develop severe acute respiratory distress syndrome (ARDS), with a current case fatality of 2.3‐3%. Diagnosis is based on clinical history and laboratory and chest radiographic findings, but confirmation currently relies on nucleic acid‐based assays. The latter are playing an important role in facilitating patient isolation, treatment and assessment of infectious activities. However, due to their limited capacity to handle an epidemic of the current scale and insufficient supply of assay kits, only a portion of suspected cases can be tested, leading to incompleteness and inaccuracy in updating new cases, as well as delayed diagnosis. Furthermore, there has not been enough time to assess specificity and sensitivity. Conventional serological assays, such as enzyme‐linked immunoassay (ELISA) for specific IgM and IgG antibodies, should offer a high‐throughput alternative, which allows for uniform tests for all suspected patients, and can facilitate more complete identification of infected cases and avoidance of unnecessary cross infection among unselected patients.
  • 《PEDIATR NEONATOL,3月10日,Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-10
    • Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children HaoHong,YuanWang,Hung-TaoChung,Chih-JungChen Show more https://doi.org/10.1016/j.pedneo.2020.03.001 Since December 2019, a novel coronavirus disease 2019 (COVID-19) caused by a novel coronavirus, SARS-CoV-2, has been emerging in Wuhan, Hubei Province, China. It has spread to other areas of China and further to more than 40 countries and regions around the world. In Singapore, Japan, Korea, Italy, and Thailand, there have been community-based infections. A few cases of pneumonia in children with SARS-CoV-2 infection were reported. Pediatric cases are mainly family cluster cases, and most of them have epidemiological links to adult patients. Pediatric clinical manifestations are not typical, and relatively milder, compared with that of adult patients.